Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Adam Wolfe

Concepts (168)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
7
2024
209
4.210
Why?
Radiation Tolerance
6
2024
83
2.980
Why?
Carcinoma, Pancreatic Ductal
4
2024
32
2.670
Why?
MicroRNAs
3
2024
350
1.190
Why?
Inflammatory Breast Neoplasms
3
2017
4
1.160
Why?
Cell Line, Tumor
12
2024
1399
1.130
Why?
Proto-Oncogene Proteins B-raf
3
2024
78
1.110
Why?
Xenograft Model Antitumor Assays
5
2024
213
1.090
Why?
Neoplastic Stem Cells
3
2016
100
1.030
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2020
1003
1.020
Why?
Lipoproteins, HDL
2
2016
18
1.010
Why?
Tumor Burden
3
2020
131
1.000
Why?
Thyroid Neoplasms
2
2024
113
0.960
Why?
CDC2 Protein Kinase
1
2024
17
0.950
Why?
Gene Expression Regulation, Neoplastic
3
2024
830
0.910
Why?
Proto-Oncogene Proteins p21(ras)
1
2024
66
0.900
Why?
Signal Transduction
4
2024
1625
0.840
Why?
DNA-Binding Proteins
1
2024
424
0.740
Why?
Neoadjuvant Therapy
2
2020
119
0.680
Why?
Neutrophils
1
2021
148
0.670
Why?
Fellowships and Scholarships
1
2020
118
0.660
Why?
Mutation
2
2024
1292
0.650
Why?
Physicians
1
2022
229
0.650
Why?
Cell Movement
2
2016
246
0.620
Why?
Forkhead Transcription Factors
2
2015
110
0.600
Why?
Melanoma
1
2021
281
0.600
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2016
137
0.580
Why?
Macrophages
2
2017
363
0.570
Why?
Paracrine Communication
1
2016
12
0.550
Why?
Breast Neoplasms
2
2016
1189
0.540
Why?
Simvastatin
1
2015
29
0.510
Why?
Interleukin-6
1
2016
266
0.490
Why?
Lipoproteins, VLDL
1
2015
9
0.490
Why?
Internship and Residency
1
2020
444
0.490
Why?
Humans
23
2024
50389
0.470
Why?
Mice, Nude
4
2024
252
0.450
Why?
Mice, SCID
3
2020
173
0.430
Why?
Animals
9
2024
13173
0.430
Why?
Mice
7
2024
5688
0.420
Why?
Inflammation
1
2016
608
0.400
Why?
Neoplasm Recurrence, Local
3
2021
634
0.380
Why?
Antineoplastic Agents
2
2016
1178
0.360
Why?
Albumins
2
2020
31
0.350
Why?
Deoxycytidine
2
2020
28
0.350
Why?
Chemotherapy, Adjuvant
2
2020
121
0.350
Why?
Paclitaxel
2
2020
83
0.340
Why?
Proportional Hazards Models
2
2021
418
0.330
Why?
Female
13
2022
26981
0.300
Why?
Aged, 80 and over
4
2021
3180
0.270
Why?
Thiazoles
2
2024
53
0.260
Why?
Cell Proliferation
3
2020
989
0.250
Why?
Retrospective Studies
3
2022
6223
0.240
Why?
Middle Aged
6
2021
12460
0.240
Why?
Quinolines
1
2024
41
0.230
Why?
Caveolae
1
2024
6
0.230
Why?
ras Proteins
1
2024
65
0.220
Why?
Endocytosis
1
2024
61
0.220
Why?
Transfection
1
2024
354
0.220
Why?
Hospitals, Community
1
2022
19
0.210
Why?
Career Mobility
1
2022
28
0.200
Why?
Arm
1
2022
48
0.200
Why?
Mentors
1
2022
55
0.200
Why?
DNA Damage
1
2024
300
0.200
Why?
Edema
1
2022
68
0.190
Why?
Neoplasm Staging
2
2021
750
0.190
Why?
Faculty, Medical
1
2022
92
0.190
Why?
Cell Cycle
2
2020
227
0.190
Why?
Caveolin 1
1
2020
21
0.180
Why?
Phosphorylation
3
2017
527
0.180
Why?
Lymphatic Metastasis
1
2021
227
0.180
Why?
Mice, Inbred NOD
1
2020
94
0.180
Why?
Faculty
1
2020
72
0.180
Why?
Leucovorin
1
2020
21
0.170
Why?
Radiotherapy, Adjuvant
1
2020
60
0.170
Why?
Fluorouracil
1
2020
56
0.170
Why?
Lymphocytes
1
2021
154
0.170
Why?
Male
7
2021
25718
0.170
Why?
Spleen
1
2021
170
0.170
Why?
Radiation Dosage
1
2021
160
0.170
Why?
Coculture Techniques
2
2017
143
0.170
Why?
Drug Administration Schedule
1
2020
369
0.170
Why?
Linear Models
1
2020
279
0.160
Why?
Survival Rate
3
2019
915
0.160
Why?
Child
2
2022
6877
0.160
Why?
Carcinoma, Non-Small-Cell Lung
1
2021
152
0.160
Why?
Radiation-Sensitizing Agents
1
2019
51
0.160
Why?
DNA Breaks, Double-Stranded
1
2019
66
0.160
Why?
Kaplan-Meier Estimate
1
2020
466
0.160
Why?
Aged
3
2021
9590
0.160
Why?
Tumor Microenvironment
2
2017
223
0.150
Why?
DNA Repair
2
2019
186
0.150
Why?
Interleukin-13
1
2017
15
0.150
Why?
STAT6 Transcription Factor
1
2017
8
0.150
Why?
Cell Polarity
1
2017
16
0.150
Why?
Adult
4
2021
13568
0.150
Why?
Interleukin-4
1
2017
44
0.150
Why?
Mice, Knockout
1
2020
840
0.150
Why?
Protein Kinase C
1
2017
70
0.140
Why?
Treatment Outcome
2
2020
5230
0.140
Why?
Cell Survival
2
2019
590
0.140
Why?
Proto-Oncogene Proteins c-akt
2
2015
155
0.140
Why?
Macrophage Colony-Stimulating Factor
1
2016
10
0.140
Why?
STAT3 Transcription Factor
1
2016
80
0.130
Why?
Adenocarcinoma
1
2020
402
0.130
Why?
Cell Dedifferentiation
1
2016
9
0.130
Why?
Head and Neck Neoplasms
1
2019
282
0.130
Why?
Neoplasm Invasiveness
1
2016
269
0.130
Why?
Histone Deacetylase Inhibitors
1
2016
57
0.130
Why?
Prognosis
1
2021
1979
0.130
Why?
Carcinoma, Ductal, Breast
1
2016
91
0.120
Why?
Tumor Stem Cell Assay
1
2015
17
0.120
Why?
Lung Neoplasms
1
2021
600
0.120
Why?
Anticholesteremic Agents
1
2015
28
0.120
Why?
Dyslipidemias
1
2015
37
0.120
Why?
Neoplasm Metastasis
1
2015
235
0.120
Why?
Intercellular Signaling Peptides and Proteins
1
2015
101
0.120
Why?
Cholesterol
1
2015
149
0.120
Why?
Regression Analysis
1
2015
396
0.110
Why?
Receptor, IGF Type 1
1
2012
20
0.110
Why?
Receptor, Insulin
1
2012
37
0.100
Why?
Brain Neoplasms
1
2016
288
0.100
Why?
src-Family Kinases
1
2012
51
0.100
Why?
Bone Diseases
1
2012
97
0.100
Why?
Time Factors
1
2016
2934
0.090
Why?
Prostatic Neoplasms
1
2012
394
0.080
Why?
Apoptosis
1
2012
1094
0.070
Why?
Protein Kinase Inhibitors
2
2019
205
0.060
Why?
Neoplasm Grading
1
2020
124
0.040
Why?
Carboplatin
1
2019
51
0.040
Why?
Chemoradiotherapy
1
2019
43
0.040
Why?
Papillomaviridae
1
2019
103
0.040
Why?
Immunotherapy
1
2021
235
0.040
Why?
Diagnosis, Differential
1
2022
1042
0.040
Why?
MAP Kinase Signaling System
1
2019
118
0.040
Why?
Radiotherapy
1
2019
124
0.040
Why?
Chemokine CCL22
1
2017
2
0.040
Why?
Phosphopeptides
1
2017
6
0.040
Why?
src Homology Domains
1
2017
8
0.040
Why?
Mannose-Binding Lectins
1
2017
10
0.040
Why?
Biomimetic Materials
1
2017
10
0.040
Why?
Enzyme Induction
1
2017
79
0.040
Why?
Lectins, C-Type
1
2017
30
0.040
Why?
Fibronectins
1
2017
39
0.040
Why?
Cisplatin
1
2019
275
0.040
Why?
Molecular Mimicry
1
2017
38
0.040
Why?
Genetic Markers
1
2017
103
0.040
Why?
Papillomavirus Infections
1
2019
168
0.040
Why?
RNA, Small Interfering
1
2017
210
0.040
Why?
Receptors, Cell Surface
1
2017
120
0.030
Why?
Randomized Controlled Trials as Topic
1
2019
556
0.030
Why?
Pentose Phosphate Pathway
1
2016
2
0.030
Why?
Glucosephosphate Dehydrogenase
1
2016
6
0.030
Why?
Gene Knockdown Techniques
1
2016
106
0.030
Why?
Receptor, erbB-2
1
2016
75
0.030
Why?
Cadherins
1
2016
64
0.030
Why?
Disease-Free Survival
1
2016
450
0.030
Why?
Phenotype
1
2017
736
0.030
Why?
Infant
1
2022
3601
0.030
Why?
Predictive Value of Tests
1
2016
934
0.030
Why?
Immunoprecipitation
1
2012
58
0.030
Why?
Triazines
1
2012
24
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
234
0.020
Why?
Tumor Cells, Cultured
1
2012
462
0.020
Why?
Pyrazoles
1
2012
111
0.020
Why?
Drug Therapy, Combination
1
2012
383
0.020
Why?
Blotting, Western
1
2012
587
0.020
Why?
Pyrimidines
1
2012
193
0.020
Why?
Disease Models, Animal
1
2016
1419
0.020
Why?
Wolfe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description